Robert T. Brooke
Vorstandsvorsitzender bei Intervene Immune, Inc.
Profil
Robert T.
Brooke is the founder of four companies.
He founded Range Impact, Inc. in 2007, Iovance Biotherapeutics, Inc. in 2007, Percipio Biosciences, Inc. in 2008, and Intervene Immune, Inc. in 2014.
At Range Impact, Inc., he held the titles of CEO, Treasurer & Director from 2014 to 2019.
At Iovance Biotherapeutics, Inc., he was the President & Chief Executive Officer from 2007 to 2011.
At Percipio Biosciences, Inc., he was the President from 2008 to 2013.
At Intervene Immune, Inc., he is currently the Chief Executive Officer & Chief Technology Officer.
Mr. Brooke's current job is as a Member at Gerontology Research Group.
Mr. Brooke received his graduate degree from the University of California, Los Angeles in 2005 and his undergraduate degree from Georgia Institute of Technology in 2003.
Aktive Positionen von Robert T. Brooke
| Unternehmen | Position | Beginn |
|---|---|---|
| Gerontology Research Group | Corporate Officer/Principal | 08.04.2010 |
Intervene Immune, Inc.
 Intervene Immune, Inc. BiotechnologyHealth Technology Intervene Immune, Inc. develops biotechnological products. It specializes in reversing thymic involution. The company was founded by Greg Fahy and Robert T. Brooke in March 2014 and is headquartered in Manhattan Beach, CA. | Vorstandsvorsitzender | 01.03.2014 |
Ehemalige bekannte Positionen von Robert T. Brooke
| Unternehmen | Position | Ende |
|---|---|---|
| RANGE IMPACT, INC. | Vorstandsvorsitzender | 08.05.2019 |
Percipio Biosciences, Inc.
 Percipio Biosciences, Inc. Medical SpecialtiesHealth Technology Percipio Biosciences, Inc. manufactures and distributes products related to oxidative stress research. The company supplies Bioxytech kits, antibodies, enzymes and other products allowing IHC, western blotting and HPLC analysis of other key biomarkers.Its line of oxidative biomarker test kits includes assays for lipid, protein and DNA determinants of oxidative mediated damage.The company was founded by Robert T. Brooke and is headquartered in Foster City, CA. | Gründer | 01.06.2013 |
| IOVANCE BIOTHERAPEUTICS, INC. | Vorstandsvorsitzender | 11.02.2011 |
| Genesis Biopharma, Inc. /Old/ | Präsident | 06.04.2010 |
| Bristol Investment Fund Ltd | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Robert T. Brooke
| University of California, Los Angeles | Graduate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| RANGE IMPACT, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Genesis Biopharma, Inc. /Old/ | Health Technology |
| Gerontology Research Group | |
Intervene Immune, Inc.
Intervene Immune, Inc. BiotechnologyHealth Technology Intervene Immune, Inc. develops biotechnological products. It specializes in reversing thymic involution. The company was founded by Greg Fahy and Robert T. Brooke in March 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
Percipio Biosciences, Inc.
Percipio Biosciences, Inc. Medical SpecialtiesHealth Technology Percipio Biosciences, Inc. manufactures and distributes products related to oxidative stress research. The company supplies Bioxytech kits, antibodies, enzymes and other products allowing IHC, western blotting and HPLC analysis of other key biomarkers.Its line of oxidative biomarker test kits includes assays for lipid, protein and DNA determinants of oxidative mediated damage.The company was founded by Robert T. Brooke and is headquartered in Foster City, CA. | Health Technology |
| Bristol Investment Fund Ltd | Miscellaneous |
Vitality Healthtech, Inc.
 Vitality Healthtech, Inc. Pharmaceuticals: OtherHealth Technology Vitality Healthtech, Inc. develops healthcare treatments and operates specialty healthcare centres. It focus on the use of cannabinoid therapies. The company is headquartered in Los Angeles, CA. | Health Technology |
